Identifying Rare Compounds with A.I‪.‬ Talking Biotech with Dr. Kevin Folta

While genomics approaches have opened a universe of new compounds in plants, the vast majority remain uncharacterized. Brightseed has employed an artificial intelligence platform to scan for novel compounds, with a goal to identify new chemicals that may play a role in human health.  Today’s podcast features Dr. Jim Flatt, CEO and Co-Founder of Brightseed.  He discusses the company’s pilot products and the pipeline of compounds that may enhance human health.